US 12,342,843 B2
Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
Michael Bernard Miklus, Essex Junction, VT (US); Anja Monika Wittke, Munich (DE); Pedro Antonio Prieto, Columbus, OH (US); and Cynthia M. Barber, Gordonsville, VA (US)
Assigned to PBM Nutritionals, LLC, Allegan, MI (US)
Filed by PBM Nutritionals, LLC, Allegan, MI (US)
Filed on Nov. 7, 2023, as Appl. No. 18/504,043.
Application 18/504,043 is a continuation of application No. 16/910,775, filed on Jun. 24, 2020, granted, now 11,849,747.
Claims priority of provisional application 62/865,874, filed on Jun. 24, 2019.
Prior Publication US 2024/0251838 A1, Aug. 1, 2024
Int. Cl. A23L 33/00 (2016.01); A23L 33/12 (2016.01); A23L 33/125 (2016.01); A23L 33/15 (2016.01); A23L 33/19 (2016.01)
CPC A23L 33/40 (2016.08) [A23L 33/12 (2016.08); A23L 33/125 (2016.08); A23L 33/15 (2016.08); A23L 33/19 (2016.08); A23V 2002/00 (2013.01)] 5 Claims
 
1. An infant formula for term infants comprising:
one or a plurality of protein components such that the total amount of protein is from about 12 g to about 19 g per reconstituted liter (RL);
one or more carbohydrate components such that the total amount of carbohydrates is from about 60 g to about 85 g per RL;
one or more human milk oligosaccharides present in the infant formula in an amount of from about 0.2 g to about 5.0 g per RL, wherein the one or more human milk oligosaccharides are selected from fucosyllactose, 2′FL, 3FL, Lacto-N-fucopentaose I (LNFP I), LNFP II, LNFP III, LNFP V, and mixtures thereof;
phospholipids in an amount of from about 300 mg to about 800 mg per RL;
phosphatidylcholine in an amount of from about 10 mg to about 300 mg per RL;
sphingomyelin in an amount of from about 20 mg to about 400 mg per RL;
one or a plurality of fat components such that the total amount of fat in the infant formula is from about 25 g to about 45 g per RL;
arachidonic acid in an amount of from about 75 mg to about 275 mg per RL;
docosahexaenoic acid in an amount of from about 37 mg to about 180 mg per RL; and
linoleic acid in and amount of from about 4500 mg to about 9500 mg per RL,
wherein the infant formula comprises a milk fat globule membrane component.